Search for: "WOCKHARDT USA, LLC" Results 1 - 10 of 10
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Sep 2013, 12:12 pm
Indianapolis, Indiana -- Alcon Research, Ltd. of Fort Worth, Texas, and Alcon Pharmaceuticals Ltd. of Fribourg, Switzerland (collectively, "Alcon") have filed a patent infringement lawsuit in the Southern District of Indiana alleging that Wockhardt Limited of Mumbai, Maharashta, India; Wockhardt Bio AG of Zug, Switzerland; Wockhardt Bio Ltd. of Zug, Switzerland; and Wockhardt USA, LLC of Parsippany, New Jersey (collectively, "Wockhardt")… [read post]
22 Sep 2013, 9:18 pm by Patent Docs
• Defendants: Wockhardt Ltd.; Wockhardt Bio AG; Wockhardt Bio Ltd.; Wockhardt USA LLC Infringement of U.S. [read post]
22 Dec 2013, 7:52 pm by Patent Docs
• Defendants: Wockhardt Ltd.; Wockhardt Bio AG; Wockhardt USA LLC Infringement of U.S. [read post]
28 Apr 2009, 9:38 pm
FoxNews reports on the settlement of a Hatch-Waxman case between Orion and Wockhardt:Orion Corporation ("Orion") and Wockhardt USA, LLC and Wockhardt Limited (together "Wockhardt") today [April 29] announce that they have executed a settlement agreement on lawsuits filed by Orion in the United States against Wockhardt regarding Wockhardt's submission of abbreviated new drug applications ("ANDAs") for… [read post]
25 Oct 2017, 6:55 am by Overhauser Law Offices, LLC
Other petitioners joined in the case are Apotex, Inc, Teva Pharmaceuticals USA, Fresenius Kabi USA, and Wockhardt Bio AG. [read post]
27 Oct 2011, 2:42 pm by FDABlog HPM
(“MGP”), a U.S. affiliate of Wockhardt USA LLC (“Wockhardt”), recently filed a brief with the Court of Common Pleas of Philadelphia County in the metoclopramide litigation refuting Plaintiff’s RLD theory of liability. [read post]
1 Apr 2010, 3:04 am
USPTO and Myriad Genetics (Docket Report) (Peter Zura's 271 Patent Blog) (Inventive Step) (Patently-O) (Holman's Biotech IP Blog) (Patent Docs) (Ladas & Parry) (Tech Transfer Blog) (ipwars.com) (Ars Technica) (BlawgIT) (IP Watch) (The Prior Art) US: Study suggests USPTO erred in broad claims of Myriad BRCA1 patent (Tech Transfer Blog) (Patent Docs) US: CAFC confirms written description requirement in Ariad v Lilly (IP Law Blog) (IP Osgoode) (IP Spotlight) (Ars Technica) US: Justifying… [read post]
28 Mar 2014, 5:33 pm
   Procedural History"Defendants-Appellants Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries, Ltd.; Lupin, Ltd.; Lupin Pharmaceuticals, Inc.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and Mylan Pharmaceuticals, Inc. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
22 Mar 2008, 2:00 am
: (IP finance),ICANN proposes new anti-domain tasting solution: (Out-Law),Three strikes, three countries:France, Japan and Sweden: (Electronic Frontier Foundation)Global - PatentsTRIPS Council: Half of WTO membership backs biodiversity amendment: (Intellectual Property Watch),The costs and benefits of patents to innovators: (Patently-O), (response from Patent Prospector),Discussion of ‘Patent Failure: How Judges, Bureaucrats, and Lawyers Put Innovators at Risk’ by economists … [read post]